NO982550D0 - 1L-13 reseptor polypeptid - Google Patents

1L-13 reseptor polypeptid

Info

Publication number
NO982550D0
NO982550D0 NO982550A NO982550A NO982550D0 NO 982550 D0 NO982550 D0 NO 982550D0 NO 982550 A NO982550 A NO 982550A NO 982550 A NO982550 A NO 982550A NO 982550 D0 NO982550 D0 NO 982550D0
Authority
NO
Norway
Prior art keywords
receptor polypeptide
polypeptide
receptor
Prior art date
Application number
NO982550A
Other languages
English (en)
Other versions
NO324775B1 (no
NO982550L (no
Inventor
Daniel Caput
Pascual Ferrara
Patrick Laurent
Natalio Vita
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO982550(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO982550D0 publication Critical patent/NO982550D0/no
Publication of NO982550L publication Critical patent/NO982550L/no
Publication of NO324775B1 publication Critical patent/NO324775B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19982550A 1995-12-06 1998-06-04 Renset peptid, isolert nukleinsyresekvens og deres anvendelse. NO324775B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514424A FR2742156A1 (fr) 1995-12-06 1995-12-06 Polypeptide recepteur de l'il-13
PCT/FR1996/001756 WO1997020926A1 (fr) 1995-12-06 1996-11-07 Polypeptide recepteur de l'il-i3

Publications (3)

Publication Number Publication Date
NO982550D0 true NO982550D0 (no) 1998-06-04
NO982550L NO982550L (no) 1998-08-05
NO324775B1 NO324775B1 (no) 2007-12-10

Family

ID=9485198

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19982550A NO324775B1 (no) 1995-12-06 1998-06-04 Renset peptid, isolert nukleinsyresekvens og deres anvendelse.
NO20074034A NO328197B1 (no) 1995-12-06 2007-08-03 Anvendelse av en probe, anvendelse av en sekvens og fremgangsmate for in vitro diagnose.
NO20092994A NO331148B1 (no) 1995-12-06 2009-09-11 Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20074034A NO328197B1 (no) 1995-12-06 2007-08-03 Anvendelse av en probe, anvendelse av en sekvens og fremgangsmate for in vitro diagnose.
NO20092994A NO331148B1 (no) 1995-12-06 2009-09-11 Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.

Country Status (19)

Country Link
US (4) US7928073B2 (no)
EP (1) EP0876482B1 (no)
JP (3) JP3415162B2 (no)
AR (2) AR004860A1 (no)
AT (1) ATE234922T1 (no)
AU (1) AU7576096A (no)
BR (1) BR9611697B1 (no)
CA (1) CA2238893C (no)
DE (1) DE69626859T2 (no)
DK (1) DK0876482T3 (no)
ES (1) ES2192620T3 (no)
FR (1) FR2742156A1 (no)
MX (1) MX9804419A (no)
MY (1) MY123740A (no)
NO (3) NO324775B1 (no)
PT (1) PT876482E (no)
TW (1) TW565570B (no)
WO (1) WO1997020926A1 (no)
ZA (1) ZA9610238B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718899C (en) * 1995-10-23 2004-01-29 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
US6911530B1 (en) 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
EP0812913A3 (en) * 1996-06-12 1999-08-04 Smithkline Beecham Corporation HR-1 receptor, a receptor of the cytokine receptors family
WO1998010638A1 (en) * 1996-09-10 1998-03-19 Amrad Operations Pty. Ltd. Therapeutic molecules
US6743604B1 (en) 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
GB9625899D0 (en) * 1996-12-13 1997-01-29 Glaxo Group Ltd Substances and their uses
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
CA2235420A1 (en) * 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
NZ512942A (en) 1998-12-14 2004-01-30 Univ Johns Hopkins Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US20020197266A1 (en) * 2000-02-08 2002-12-26 Waldemar Debinski Immunotherapy using interleukin 13 receptor subunit alpha 2
AU2001253282A1 (en) 2000-04-07 2001-10-23 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
CN1688340A (zh) 2002-07-15 2005-10-26 韦思公司 调节t辅助(th)细胞发育和功能的方法和组合物
EP1703893B1 (en) 2003-12-23 2012-04-11 Genentech, Inc. Novel anti-il 13 antibodies and uses thereof
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
RU2416412C2 (ru) 2004-10-29 2011-04-20 Топиджен Фармасьютикалз Инк. Антисмысловые олигонуклеотиды для лечения аллергии и пролиферации неопластических клеток
EP1824886B1 (en) 2004-11-17 2010-12-22 Amgen Inc. Fully human monoclonal antibodies to il-13
GB0615881D0 (en) * 2006-08-10 2006-09-20 Univ Southampton Novel peptide for treatment of asthma
EP2137215A2 (en) * 2007-04-23 2009-12-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
EP2850093B1 (en) 2012-01-27 2019-01-09 The Board of Trustees of the Leland Stanford Junior University Therapeutic il-13 polypeptides
US9868788B2 (en) * 2013-03-15 2018-01-16 Wake Forest University Health Sciences Antibodies against human and canine IL-13RA2
CA3184564A1 (en) 2013-09-13 2015-03-19 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2
KR102332302B1 (ko) 2013-09-13 2021-12-01 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
US10093708B2 (en) 2013-09-24 2018-10-09 Medicenna Therapeutics Inc. Interleukin-4 receptor-binding fusion proteins and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US6911530B1 (en) * 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
US5710023A (en) * 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain

Also Published As

Publication number Publication date
US20060035856A1 (en) 2006-02-16
JP2003180382A (ja) 2003-07-02
CA2238893C (fr) 2013-10-08
ATE234922T1 (de) 2003-04-15
DE69626859D1 (de) 2003-04-24
PT876482E (pt) 2003-07-31
AR056723A2 (es) 2007-10-17
FR2742156A1 (fr) 1997-06-13
BR9611697A (pt) 1999-02-17
ES2192620T3 (es) 2003-10-16
EP0876482B1 (fr) 2003-03-19
CA2238893A1 (fr) 1997-06-12
JP3737793B2 (ja) 2006-01-25
MX9804419A (es) 1998-09-30
US20110201029A1 (en) 2011-08-18
JP2005323595A (ja) 2005-11-24
NO324775B1 (no) 2007-12-10
NO20074034L (no) 1998-08-05
MY123740A (en) 2006-06-30
US8318910B2 (en) 2012-11-27
WO1997020926A1 (fr) 1997-06-12
JP4185070B2 (ja) 2008-11-19
JP3415162B2 (ja) 2003-06-09
DE69626859T2 (de) 2003-12-24
TW565570B (en) 2003-12-11
DK0876482T3 (da) 2003-07-21
NO20092994L (no) 1998-08-05
AU7576096A (en) 1997-06-27
AR004860A1 (es) 1999-03-10
NO982550L (no) 1998-08-05
BR9611697B1 (pt) 2013-09-17
US20050282216A1 (en) 2005-12-22
US7928073B2 (en) 2011-04-19
US20060035855A1 (en) 2006-02-16
ZA9610238B (en) 1998-06-05
NO328197B1 (no) 2010-01-04
JPH11511028A (ja) 1999-09-28
NO331148B1 (no) 2011-10-24
EP0876482A1 (fr) 1998-11-11

Similar Documents

Publication Publication Date Title
NO982550D0 (no) 1L-13 reseptor polypeptid
FI935175A (fi) Tyrosinkinas- HER4-humanreceptor
NO961796D0 (no) Rekombinante fedme (ob) proteiner
NO972016D0 (no) Indolyl-Y-reseptorantagonister
FI921740A (fi) Hybrid polypeptid
DE69735926D1 (de) Interleukin-18 Rezeptorproteine
DE69612316T2 (de) Gelenkige Armlehne
DK162890D0 (da) Polypeptid
NO944112L (no) Rekombinat stimuleringsfaktor for neu-reseptoren
NO976058L (no) Rekombinant mistellectin
DE69529982D1 (de) Bakteriozin
BR9609671A (pt) Amino uracilas substituídas
NO974924L (no) Modifiserte polypeptider med öket immunogenisitet
NO980375D0 (no) Humant MP52 Arg protein
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
BR9605220B1 (pt) gonadotropinas recombinantes.
DE69434900D1 (de) Menschliche chemokin-polypeptide
DE69739053D1 (de) Polypeptid mit beta-Fructofuranosidase-Aktivität
DK185590D0 (da) Polypeptid
DK236190D0 (da) Polypeptid
DK106390D0 (da) Polypeptid
DK111891D0 (da) Polypeptid
GB9007065D0 (en) Recombinant protein receptor

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees